Molecular response assessment by quantitative real-time polymerase chain reaction after induction therapy in NPM1-mutated patients identifies those at high risk of relapse

Monitoring minimal residual disease is an important way to identify patients with acute myeloid leukemia at high risk of relapse. In this study we investigated the prognostic potential of minimal residual disease monitoring by quantitative real-time polymerase chain reaction analysis of NPM1 mutatio...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Hubmann, Max, Köhnke, Thomas, Hoster, Eva, Schneider, Stephanie, Dufour, Annika, Zellmeier, Evelyn, Fiegl, Michael, Braess, Jan, Bohlander, Stefan K., Subklewe, Marion, Sauerland, Maria-Cristina, Berdel, Wolfgang E., Büchner, Thomas, Wörmann, Bernhard, Hiddemann, Wolfgang, Spiekermann, Karsten
Format: Artigo
Idioma:Inglês
Publicat: Ferrata Storti Foundation 2014
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4116830/
https://ncbi.nlm.nih.gov/pubmed/24816240
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2014.104133
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars